Regencell Bioscience Holdings Limited (RGC)
RGC Chart as of 2025-03-13
Stock Information
| CEO: | – |
| CFO: | – |
| Employees: | 12 |
| Address: | Chinachem Leighton Plaza, Causeway Bay, Hong Kong |
| Country: | Hong Kong |
| Website: | https://www.regencellbioscience.com |
| Listing Date: | – |
| Founded: | – |
| Founder: | – |
| Current Price: | 14.09000015258789 USD |
| Today Change: | 224.65% |
| Outstanding Shares: | 13,012,900 |
| Volume: | 22,740,856 |
| Avg Volume: | 409,189 |
| Expert Target Price: | – (Institutions: 0) |
| EPS: | – |
| PER: | – |
| Dividend Date: | – |
| Last Split Date: | – |
| Last Split Factor: | – |
Key Executives
| Name | Title | Pay | Year |
|---|---|---|---|
| Mr. Yat-Gai Au | Founder, Chairman & CEO | — | — |
| Ms. Michelle Chan | Financial Controller & Principal Financial Officer | — | — |
| Mr. Wai Hong Chung | COO, Chief Strategy Officer & Director | 245.64k | — |
| Ms. Antonia Assang | Senior Vice President of Project Management | — | — |
| Mr. Yat-Pui Au | Chief Business Officer | — | — |
Financials
Income Statement
| Metric | Amount |
|---|---|
| Total Revenue | 0 |
| Cost Of Revenue | – |
| Gross Profit | – |
| Operating Income | -4,736,726 |
| Net Income | -4,301,837 |
Balance Sheet
| Metric | Amount |
|---|---|
| Total Assets | 8,438,211 |
| Total Liabilities | – |
| Total Stockholder Equity | – |
Cash Flow
| Metric | Amount |
|---|---|
| Total Cash From Operating Activities | – |
| Capital Expenditures | – |
SEC Filings (Gemini Summaries)
| AccNo | Date | Summary |
|---|---|---|
| 0001213900-25-023407 | 2025-03-13 | This SEC filing text defines CSS styles for formatting text boxes and tables. It specifies borders, fonts, colors, and alignment for various table elements. |
| 0001213900-25-003587 | 2025-01-15 | Regencell Bioscience (Jan 2025 6-K) reports directors/employees extended stock lock-up until April 20, 2026. |
| 0001213900-24-090791 | 2024-10-25 | RegenCell BioScience Holdings Limited’s 20-F annual report for fiscal year ended June 30, 2024. Filed with SEC. Ordinary shares (RGC) listed on Nasdaq. 13,012,866 shares outstanding. Not a seasoned, accelerated, or large accelerated filer. |
| 0001213900-24-054042 | 2024-06-20 | Regencell filed a 6-K report (June 2024) furnishing its unaudited financials for the six months ended December 31, 2023, per Nasdaq Rule 5250(c)(2). (Exhibit 99.1). |
| 0001213900-24-000003 | 2024-01-02 | Regencell Bioscience (Form 6-K): Director Yi-Chung Chao resigned (personal reasons, no disagreement) effective 12/27/23. James Wai Hong Chung (COO) was appointed as Director 12/28/23, receiving HK$84,000 annual director fee. |
News Summary
– Catalunya prevé asumir por completo la gestión del Ingreso Mínimo Vital en 2026
2025-03-05 12:17:22 | Eldiario.es
La Seguridad Social suspende el ingreso mínimo vital a familias por retrasos de gestión. El 67% de quienes podrían recibir esta prestación en Catalunya no lo hacen.
Link
– Retroid Pocket Mini Scaling Issue Deemed Unfixable, $10 Discount Announced For Customers
2025-03-11 21:33:02 | Techpowerup.com
The Retroid Pocket Mini was announced with an AMOLED display boasting a resolution of 1280 x 960, which was plenty for its tiny 3.7-inch display. However, the product has suffered from a pretty severe scaling issue.
Link
– RGC Resources (NASDAQ:RGCO) Upgraded to Hold at StockNews.com
2025-02-18 06:16:52 | ETF Daily News
RGC Resources (NASDAQ:RGCO – Get Free Report) was upgraded by equities researchers at StockNews.com from a ‘sell’ rating to a “hold” rating. RGC Resources stock o…
Link
– Глаза и мозг: коррекция изображения в движении
2025-02-14 08:00:14 | Habr.com
Между технологиями и биологическими системами часто существует много общего, особенно если та или иная технология создавалась с оглядкой на биологию. Однако некоторые биологические системы, как бы сильно ни старались ученые и инженеры, все равно превосходят и…
Link
– huaweicloudsdkrgc 3.1.137
2025-02-27 08:55:38 | Pypi.org
RGC
Link
Analysis of Today’s Move
RGC Resources (RGCO) stock experienced a rally today. The upgrade to “hold” from “sell” by StockNews.com likely contributed. This positive shift in analyst sentiment often attracts investors. The upgrade suggests a more stable outlook for the stock. Previously, investors may have been hesitant to buy.
The news itself might not be overwhelmingly positive. A “hold” rating implies neither strong buy nor sell advice. However, it signals reduced downside risk perceived by the analysts. This can still be a catalyst for price appreciation. Investors may interpret it as a stabilization signal.
While the news about the Retroid Pocket Mini is negative, it is unrelated. Similarly, the Catalunya news and the Huawei SDK are irrelevant. The eye-tracking article is also outside the scope of this analysis. Therefore, these news items likely had no influence.
Regencell Bioscience (RGC) filings may have caused confusion. The similarity in ticker symbols may mislead some investors. However, the lock-up extension until 2026 is old news. Therefore, it’s less likely to be the primary driver for the recent rally.
In summary, the analyst upgrade appears to be the primary factor. This positive signal likely led to increased buying pressure. While other news existed, it’s less probable they were significant. The upgrade offered a catalyst for renewed investor interest.
This stock has shown a change of 224.65% today.
Please consider that all investment decisions carry risk;
none of the content here should be construed as financial advice.
Always do your own research or consult a professional before making investment decisions.
The information provided in this article is for informational purposes only
and does not constitute legal, tax, or investment advice.
Investing involves risk, including the potential loss of principal.
Leave a Reply